Published in
Elsevier, Digestive and Liver Disease, 6(48), p. 650-655, 2016
DOI: 10.1016/j.dld.2016.02.004
Links
Tools
Dual Therapy with Peg-Interferon and Ribavirin in Thalassemia Major Patients with Chronic HCV Infection: Is There Still an Indication?
Journal article published in 2016 by
Vito Di Marco,
Roberta D’Ambrosio,
Fabrizio Bronte 
,
Giorgio Saracco ,
Alfonso Galeota Lanza,
Gianluca Forni,
Zelia Borsellino,
Erika Poggiali,
Liana Cuccia,
Aurelio Maggio,
Vincenza Calvaruso,
Salvatore Madonia,
Flavia Fiorenza,
Antoninio Salvo,
Calogera Gerardi
and other authors.
,
Giorgio Saracco ,
Alfonso Galeota Lanza,
Gianluca Forni,
Zelia Borsellino,
Erika Poggiali,
Liana Cuccia,
Aurelio Maggio,
Vincenza Calvaruso,
Salvatore Madonia,
Flavia Fiorenza,
Antoninio Salvo,
Calogera Gerardi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Iron overload and hepatitis C virus (HCV) infection together can lead to chronic liver damage In thalassemia major (TM) patients.